Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Procter & Gamble Company (PG): Investing in the Coupon Nation

During the recent stretch of economic uncertainty, a growing number people started to rely on coupons when they shopped.

This means people are looking for value — and trying to cut budget corners everywhere they can. As customers look for value, they naturally gravitate toward certain companies that cater to cost-conscious customers. These companies will likely see a pickup in sales and market share. If they are careful to properly discount the products so that the additional sales compensate for the price breaks, these companies should also see a rise in earnings. Savvy investors can find stores and businesses that will benefit from this new value-oriented coupon culture. Can an investor take advantage of this trend?

In this post, I’ll take a look at some of the companies that will most likely benefit from the consumer-savvy shopping trend, including companies that produce products that coupon-clippers tend to favor, as well as companies that see a boost in revenue when customers are trying to find ways to save money. Because it’s very easy for companies to chase sales at the expense of revenue, we want to look at earnings and revenue performance over the past few years.

Finally, we’ll carefully weigh how these companies manage their earnings because firms that don’t manage price discounts tend take damage to their own bottom line.

Head and Shoulders above the rest?

The Procter & Gamble Company (NYSE:PG)The first pick for the coupon culture is The Procter & Gamble Company (NYSE:PG). The company produces some of the world’s most recognized brands, like Head & Shoulders, Crest, and Gillette, and employs an all-out marketing juggernaut to make sure cost-conscious consumers pull their products from the shelves.

Revenue at The Procter & Gamble Company (NYSE:PG) has had its ups and downs over the past three years. In 2010, the company pulled in $79.57 billion and jumped the following year to $85.14 billion. The next year, revenue settled back to a little over $83 billion.

Earnings rocked back and forth, too, but with better results for the shareholder. In 2010, earnings-per-share (EPS) were tagged at $3.87, but dipped slightly to $3.56 in 2011. However, the latest figures — for 2012 — show robust earnings growth. The company reported an EPS of $4.61.

Experts are expecting The Procter & Gamble Company (NYSE:PG) to grow its earnings in double-digits in the next year. Experts are betting on earnings to be about $4.03 per share and are forecasting $4.33 in 2014.

The recent stutter step in earnings and revenue growth may be one reason the company has asked former Chief Executive Officer, A.G. Lafley, to come back. Let’s see if he can restore the solid growth, because, as we’ll see, he has competition.

Tea time

Let’s take a look at Unilever. In a lot of ways, Unilever is a The Procter & Gamble Company (NYSE:PG) investor’s best frenemy. Sure, it’s competing in the same market as Procter & Gamble and it’s always poised to take market share from the consumer products giant, but Unilever makes sure its competitors bring its A-game all the time.

Like The Procter & Gamble Company (NYSE:PG), it’s competing on a global stage, but American consumers — and their coupon-clipping proclivities — are still valued customers of Unilever products, such as Lipton tea, Degree antiperspirant, and Dove soap.

The latest figures only go back to mid-2012, but it’s earnings and revenue picture looks similar to its old anti-buddy The Procter & Gamble Company (NYSE:PG).  From 2009 to 2010, revenue dipped from $59 billion to $55.76 billion. At the mid-point of 2011, revenue was rebounding, already at $29 billion.

Likewise, earnings per share show a little bit of a bounce. The total in 2009 was $2.26, then falling to $1.88 in 2010. Halfway through 2011, the EPS, at $1.02, was already showing signs of recovery, each of the two first quarters bested the first two quarters of 2009 and 2010.

Analysts think that Unilever will grow at rates about equal to its competitor, The Procter & Gamble Company (NYSE:PG). For December 2013, the earnings are expected to be $2.22 and that should increase to $2.41 the following year, for about a 8% increase.

Brush up on revenue

Colgate-Palmolive Company (NYSE:CL) doesn’t have quite the diverse product offerings as either The Procter & Gamble Company (NYSE:PG) or Unilever, but it knows how to market to thrifty consumers. Its concentration on certain product areas — mostly oral and personal hygiene — can actually be an advantage. It has far less iron in the fire than its larger competitors, allowing it to focus on building those product lines. At least, that’s how it’s supposed to work on the store shelves; let’s see if that strategy is working on the company’s bottom line.

The company has shown strong one-year, three-year and five-year revenue and EPS growth.

In 2010, total revenue was a little over $15.5 billion and then jumped to more than $16.7 billion in 2011. Revenue edged up a little the following year to $17.09 billion.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.